Submit Release
News Search

There were 907 press releases posted in the last 24 hours and 442,554 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GSK receives positive opinion from the CHMP in Europe for once-weekly EperzanTM (albiglutide) for the treatment of type 2 diabetes

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.

We use cookies to enhance your experience. Learn more